Brief: Pure Biologics Files To Polish Financial Regulator KNF For Approval Of Prospectus Regarding Co's Shares
03/08/2020 14:48
Aug 3 (Reuters) - Pure Biologics SA PUR1.WA :
* FILES TO POLISH FINANCIAL REGULATOR KNF FOR APPROVAL OF
CO'S
PROSPECTUS FOR INTRODUCING A, B1, B2, C, D, E SERIES SHARES ON
WARSAW STOCK EXCHANGE
Source text for Eikon: ID:nEM7V7xJfa
Further company coverage: PUR1.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Multiqure SA
See all newsBrief: Selvita To Expand Its Operations Through New Biological Drug Business
Brief: Pure Biologics FY Net Loss Widens To 25.6 Mln Zlotys
Brief: Pure Biologics Signs Term Sheet With ACRX Investments On Potential Financing
Brief: Pure Biologics Signs Deal For Subsidy With Poland's Medical Research Agency
Brief: Pure Biologics To Seek Extra Financing For PB003 And PB004 Projects